Alfama's Unattributed VC - III Round

Alfama raised a round of funding on October 15, 2008.

Alfama specializes in the development of Carbon Monoxide-Releasing Molecules (CORMs) for therapy. The company produces CORMs and obtained exceptional results in various animal models of chronic and ac…

Articles about Alfama's Unattributed VC - III Round: